Progressive Corporation
PGR
$215.69
+4.01%
The Progressive Corporation is a leading provider of personal and commercial auto insurance, along with specialty lines and homeowners insurance, operating within the US property and casualty insurance industry. It is a market leader distinguished by its pioneering use of telematics and direct-to-consumer sales channels, which have historically driven superior underwriting efficiency and customer acquisition. The current investor narrative centers on the stock's significant underperformance relative to the broader market, driven by concerns over margin pressures from claims inflation and a potential cyclical downturn in the P&C insurance sector, despite the company's strong underwriting machine and recent revenue growth.…
PGR
Progressive Corporation
$215.69
Related headlines
Investment Opinion: Should I buy PGR Today?
Rating: Buy. The core thesis is that Progressive's current price offers a compelling entry point into a financially superb company trading at a deep discount due to transient sector fears and negative momentum.
The recommendation is supported by four key data points: 1) The PEG ratio of 0.35 signals extreme undervaluation relative to growth, 2) The trailing P/E of 11.81x is at a discount to its own recent historical valuation, 3) Underlying business health is strong with 12.19% YoY revenue growth and a 37.29% ROE, and 4) The company generates massive free cash flow ($17.20B TTM) to fund dividends (2.15% yield) and create shareholder value. Compared to typical financial sector valuations, these metrics are attractive for a market leader.
The two biggest risks are a further deterioration in underwriting margins (gross profit) and a continuation of the severe technical downtrend breaking the $189 support. This Buy rating would downgrade to Hold if quarterly revenue growth decelerates below 8% or net margin falls consistently below 11%. It would downgrade to Sell if the stock breaks and sustains below the $189.20 52-week low on worsening fundamentals. Relative to its own history and the strength of its fundamentals, the stock is undervalued, offering a favorable risk/reward for patient investors.
Sign up to view all
PGR 12-Month Price Forecast
The AI assessment is bullish based on the severe dislocation between Progressive's strong fundamentals and its battered stock price. The company is a high-quality operator (37.29% ROE) growing revenue at a double-digit clip, yet it is priced as if it is in permanent decline (P/E 11.81x, near historical lows). The medium confidence reflects the real near-term headwinds from sector cyclicality and poor technical momentum, which could delay a realization of value. The stance would upgrade to high-confidence bullish on a confirmed technical reversal above the $215 resistance level coupled with a quarter of margin stability. It would downgrade to neutral if revenue growth decelerates sharply or the $189 support level fails.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Progressive Corporation's 12-month outlook, with a consensus price target around $280.40 and implied upside of +30.0% versus the current price.
Average Target
$280.40
4 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
4
covering this stock
Price Range
$173 - $280
Analyst target range
Analyst coverage for Progressive is limited in the provided dataset, with only 4 analysts contributing to estimates, which is surprisingly low for a large-cap company and may indicate data sourcing limitations rather than actual coverage. The consensus sentiment, based on recent institutional ratings, appears mixed to neutral, with actions from firms like Morgan Stanley (Underweight), B of A Securities (Buy), Jefferies (Hold), and UBS (Neutral) pointing to a lack of strong bullish conviction. The average revenue estimate for the forward period is $99.44 billion, with a very tight range between $99.14B and $99.75B, indicating high certainty on the top-line forecast, while the EPS estimate average is $16.00 with a wider range from $13.90 to $20.12, reflecting greater uncertainty on profitability. The wide target price range implied by the EPS estimates, coupled with the prevalence of Hold/Neutral ratings, signals high uncertainty among analysts regarding the stock's near-term catalysts and the resolution of margin pressures facing the P&C insurance sector.
Bulls vs Bears: PGR Investment Factors
The investment debate for Progressive hinges on a clash between exceptional fundamental strength and severe technical/market sentiment weakness. The bull case, currently supported by stronger quantitative evidence, is built on deep value metrics (PEG 0.35, P/E 11.81x), fortress-like financials (ROE 37.29%, D/E 0.23), and robust underlying growth (12.19% YoY revenue growth). The bear case is driven by the stock's catastrophic relative performance (-46.29% vs. SPY), volatile quarterly earnings reflecting industry headwinds, and a clear lack of bullish catalyst recognition from analysts. The single most important tension is whether the company's superior underwriting machine and financial strength can overcome the cyclical pressures and negative momentum currently dominating the stock price. The resolution of this tension—specifically, a stabilization or improvement in quarterly profitability margins—will determine the thesis direction.
Bullish
- Deeply Undervalued PEG Ratio: The PEG ratio of 0.35, based on trailing P/E and growth, suggests the stock is significantly undervalued relative to its earnings growth rate. This is a classic value indicator, implying the market is overly pessimistic about future prospects.
- Exceptional Financial Strength: Progressive boasts a robust balance sheet with a low debt-to-equity ratio of 0.23 and a stellar return on equity of 37.29%. This financial fortress provides resilience during industry downturns and supports shareholder returns.
- Strong Revenue Growth Trajectory: Q4 2025 revenue grew 12.19% year-over-year to $22.74 billion, with sequential quarterly growth from $20.40B to $22.74B throughout the year. This demonstrates the core business is expanding despite sector headwinds.
- Massive Free Cash Flow Generation: The company generates enormous free cash flow, with TTM FCF of $17.20 billion. This high FCF/Share underpins the sustainable 2.15% dividend yield and provides capital for strategic initiatives or buybacks.
Bearish
- Severe Technical Downtrend: The stock is down 21.30% over the past year, underperforming the S&P 500 by a staggering 46.29%. Trading just 8.3% above its 52-week low of $189.20, it exhibits classic 'falling knife' characteristics with no clear reversal signal.
- Volatile & Pressured Profitability: Quarterly net income has been volatile, swinging from $2.57B to $3.18B to $2.62B before Q4's $2.95B. The gross margin of 29.28% in Q4, while improved from Q3's 15.76%, highlights ongoing pressure from claims inflation.
- Analyst Uncertainty & Lack of Conviction: Analyst coverage is limited (4 analysts) with a mixed sentiment (Underweight, Buy, Hold, Neutral). The wide EPS estimate range ($13.90 to $20.12) reflects high uncertainty about near-term earnings power.
- Cyclical Sector Headwinds: As a P&C insurer, Progressive faces a potential cyclical downturn with margin pressures from claims inflation. The stock's underperformance is the market pricing in this sector-wide risk, which may persist.
PGR Technical Analysis
The stock is in a pronounced downtrend, having declined 21.30% over the past year, which starkly contrasts with the S&P 500's 24.99% gain, resulting in severe relative weakness of -46.29%. With a current price near $204.87, it is trading approximately 23.5% below its 52-week high of $267.93 and only 8.3% above its 52-week low of $189.20, positioning it in the lower quartile of its annual range and signaling a deep value or 'falling knife' scenario. The short-term momentum shows a modest 0.99% gain over the past month, which diverges positively from the longer-term downtrend, but the 3-month performance remains negative at -0.55%, indicating a tentative stabilization rather than a decisive reversal. The stock's beta of 0.27 indicates it has been significantly less volatile than the market during this decline, which is unusual for a downtrending stock and may suggest defensive characteristics or limited speculative interest. Key technical support is clearly defined at the 52-week low of $189.20, while resistance lies at the recent failed recovery highs around $213-$215; a sustained break below $189 would likely trigger a new leg down, whereas a move above $215 could signal the beginning of a more meaningful recovery phase.
Beta
0.27
0.27x market volatility
Max Drawdown
-34.1%
Largest decline past year
52-Week Range
$189-$268
Price range past year
Annual Return
-19.0%
Cumulative gain past year
| Period | PGR Return | S&P 500 |
|---|---|---|
| 1m | +8.1% | -1.6% |
| 3m | +6.3% | +11.7% |
| 6m | -5.3% | +6.3% |
| 1y | -19.0% | +22.2% |
| ytd | +1.7% | +7.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
PGR Fundamental Analysis
Revenue growth remains robust, with the most recent quarterly revenue of $22.74 billion representing a 12.19% year-over-year increase, and the sequential trend from Q1 to Q4 2025 shows consistent quarterly revenue growth from $20.40B to $22.74B. The Personal Lines Segment, at $18.71 billion, is the primary growth driver, vastly outweighing the Commercial Lines Segment at $2.68 billion, indicating the core consumer auto business is fueling expansion. The company is highly profitable, reporting net income of $2.95 billion for Q4 2025 and a trailing net margin of 12.90%, with gross margin for the quarter at 29.28% and operating margin at 16.16%. Profitability has been volatile on a quarterly basis, with net income swinging from $2.57 billion in Q1 to $3.18 billion in Q2, then to $2.62 billion in Q3, before the Q4 result, reflecting the inherent earnings cyclicality of the insurance underwriting cycle. The balance sheet is exceptionally strong with a low debt-to-equity ratio of 0.23 and a robust return on equity of 37.29%, while the company generates massive free cash flow, with TTM FCF of $17.20 billion yielding a high FCF/Share. The current ratio of 0.59 is low but typical for insurers whose liabilities are primarily claim reserves, and the strong cash generation supports the dividend, which has a payout ratio of 25.39% and a yield of 2.15%.
Quarterly Revenue
$22.7B
2025-12
Revenue YoY Growth
+0.12%
YoY Comparison
Gross Margin
+0.29%
Latest Quarter
Free Cash Flow
$17.2B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is PGR Overvalued?
Given a positive net income of $2.95 billion, the primary valuation metric is the P/E ratio. The trailing P/E is 11.81x, while the forward P/E is slightly higher at 12.64x; the narrow gap suggests the market expects only modest earnings growth in the near term. Compared to sector averages (implied but not provided in the data), the trailing P/E appears reasonable for a financially strong company, though the PS ratio of 1.52x and EV/Sales of 1.41x provide alternative checks suggesting the market is valuing sales modestly. The stock's valuation is near the bottom of its own historical range, as its current trailing P/E of 11.81x is below the historical P/E figures from recent quarters, which have ranged from 11.35x to over 16x in 2025, indicating the market is pricing in pessimistic expectations relative to its own recent history. The PEG ratio of 0.35, based on trailing metrics, suggests the stock is deeply undervalued relative to its growth rate, but this may reflect market skepticism about the sustainability of recent growth amid industry headwinds.
PE
11.8x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range -31x~137x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
9.5x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks center on earnings volatility and sector cyclicality. Progressive's net income has shown significant quarterly swings (e.g., $3.18B in Q2 2025 to $2.62B in Q3), reflecting the inherent unpredictability of the underwriting cycle. While the balance sheet is strong (D/E 0.23), the low current ratio of 0.59, though typical for insurers, underscores the liability-heavy nature of the business. The primary risk is that sustained claims inflation continues to compress the gross margin, which dipped to 15.76% in Q3 2025 before recovering to 29.28% in Q4, threatening the high ROE of 37.29%.
Market & Competitive Risks are pronounced given the stock's valuation compression and sector sentiment. Trading at a trailing P/E of 11.81x, near the bottom of its recent historical range, the stock faces valuation compression risk if the P&C insurance sector remains out of favor. Its beta of 0.27 indicates it has been less volatile than the market during its decline, which may paradoxically limit upside participation in a broad market rally. Competitive and regulatory pressures in the core U.S. auto insurance market, coupled with potential adverse regulatory changes, pose persistent external threats to pricing power and growth.
Worst-Case Scenario involves a deepening of the current P&C insurance hard market downturn, where claims severity outpaces premium rate increases for multiple quarters. This could trigger a sequence of earnings misses, analyst downgrades, and a breach of key technical support. The realistic downside is anchored to the 52-week low of $189.20, which represents a -7.7% decline from the current ~$204.87. In a severe adverse scenario, a re-test of the 52-week low is likely, implying a potential loss of -7% to -8%. A break below that level could see a drop toward the $180s, extending the loss to -12% or more, especially if the max drawdown of -34.06% from the high serves as a reminder of the stock's vulnerability in a full risk-off environment for the sector.
FAQ
The key risks are: 1) Cyclical & Profitability Risk: Volatile quarterly earnings (e.g., Q3 2025 net income of $2.62B vs. Q2's $3.18B) and pressure on gross margins from claims inflation. 2) Technical & Sentiment Risk: The stock is in a severe downtrend, down 21.30% over the past year and underperforming the S&P 500 by 46.29%, indicating powerful negative momentum. 3) Sector Concentration Risk: Heavy reliance on the Personal Auto segment ($18.71B in Q4), making it vulnerable to U.S. auto market disruptions. 4) Analyst Uncertainty: Limited coverage with mixed ratings and a wide EPS estimate range ($13.90 to $20.12), reflecting low consensus conviction.
The 12-month forecast presents three scenarios. The Base Case (55% probability) sees a gradual recovery to a range of $215-$235, assuming steady execution and EPS near the analyst average of $16.00. The Bull Case (30% probability) projects a rally to $240-$260 on margin expansion and multiple re-rating. The Bear Case (15% probability) warns of a retest of the $189-$200 range if margin pressures worsen. The base case is most likely, anchored by the analyst EPS consensus and the expectation that the current deep undervaluation will gradually correct as the company demonstrates operational resilience.
PGR is significantly undervalued relative to its growth and financial strength. The primary metric, the trailing P/E of 11.81x, is below its own recent historical average. The PEG ratio of 0.35 is a glaring signal of undervaluation, suggesting the market is pricing in negligible or negative growth for a company growing revenue at 12%. Compared to the broader market and its historical self, the stock is trading at a discount. This valuation implies the market expects a prolonged period of margin pressure and poor earnings, a view that appears overly pessimistic given the company's robust fundamentals.
For value investors with a medium-term horizon, PGR presents a compelling opportunity. The stock is deeply undervalued based on its PEG ratio of 0.35 and trades at a trailing P/E of 11.81x near the bottom of its historical range, while the underlying company is financially exceptional with a 37.29% ROE and 12.19% revenue growth. The biggest downside risk is a continuation of the severe technical downtrend, with support at $189.20. It is a good buy for those who believe the company's fundamentals will ultimately outweigh transient sector fears, but it may not be suitable for short-term traders or those sensitive to momentum.
PGR is primarily suitable for a long-term investment horizon of 2-3 years or more. Its low beta of 0.27 suggests it is not a high-volatility trading vehicle, and the investment thesis is based on the market eventually recognizing fundamental value, which can be a slow process. The 2.15% dividend yield adds an income component supportive of long-term holding. The stock's current technical weakness and sector headwinds make it poorly suited for short-term trading. A minimum holding period of 12-18 months is recommended to allow for the potential resolution of cyclical pressures and the realization of the value gap.